Tadalafil Daily Used Post Turp
Completed
- Conditions
- Erectile Dysfunction Following Urethral Surgery
- Interventions
- Drug: Placebo
- Registration Number
- NCT06788704
- Lead Sponsor
- Kafrelsheikh University
- Brief Summary
to assess the effect of early tadalafil 5 mg once daily on persistent storage lower urinary tract symptoms (LUTS) and erectile function after transurethral resection of the prostate (TURP).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 270
Inclusion Criteria
- sexual active men
Exclusion Criteria
- sexual inactive men
- cardiac patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patient recive tadalafil 5mg once daily early post turp Tadalafil 5mg - Patient recive placebo once daily early post turp Placebo -
- Primary Outcome Measures
Name Time Method Assess erectile function 3 month Usine IIEF score
- Secondary Outcome Measures
Name Time Method Assess storage symptoms 3 month Using IPSS score
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Tadalafil's effect on post-TURP LUTS and erectile dysfunction?
How does Tadalafil 5mg compare to standard PDE5 inhibitors in post-TURP erectile dysfunction management?
Which biomarkers predict response to Tadalafil in persistent storage LUTS after prostate surgery?
What are the long-term adverse events of Tadalafil 5mg in post-TURP patients versus placebo?
How do combination therapies of Tadalafil and alpha-blockers improve post-TURP urological outcomes?
Trial Locations
- Locations (1)
Elsayed Abdelhalim Elsayed
🇪🇬Zagazig, Egypt